Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retplase injection through external ventricular drain for traumatic intracranial hemorrhage
IRCT20221108056446N23Phase 2Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of reteplase in intracerebral hemorrhage (ICH) and traumatic brain injury (TBI) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Bleeding. Started Jul 2026; status: recruiting.
02
Drugs
reteplase
03
Conditions
intracerebral hemorrhage (ICH)traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20221108056446N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221108056446N23.